WHC is still in active development. Read this to understand our approach.
depiction of RWSXRVCMGQZWBV-UHFFFAOYSA-N.svg
drugmap

Glutathione

Check on drugmap

Data

InChI: InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)

Synonyms: Glutathione 100 microg/mL in Acetonitrile:Water,Cys(N-.gamma.Glu-)-Gly,Spectrum2_001500,BDBM50422268,CHEBI:60836,[Glu(-Cys)]n-Gly,GLUTATHIONE [MI],EINECS 200-725-4,L-Glutathione (reduced form),gamma-L-Glutamylcysteinylglycine, L-gamma-glutamyl-L-cysteinylglycine,Glycine, L-.gamma.-glutamyl-L-cysteinyl-,NCGC00094976-01, Glutathione SH,Agifutol S,Z2183947556,GTPL6737,SDCCGMLS-0066687.P001,KBio2_003467,Glutathione, United States Pharmacopeia (USP) Reference Standard,Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl),Glutathione SH,SPBio_001519,NSC 400639,N-(N-L-?-Glutamyl-L-cysteinyl)glycine, reduced glutathione,DTXCID903101,C10H17N3O6S,reduced glutathione,SMP1_000247,EN300-311690, Triptide, GSH,gam.-L-Glutamyl-L-cysteinyl-glycine,UNII-GAN16C9B8O,Deltathione,glutathione red,bmse000952,gamma-L-glutamyl-L-cysteinyl-glycine,HY-D0187, Agifutol S, 5-L-Glutamyl-L-cysteinylglycine,IDI1_000075, Glutatione,Spectrum5_000940,Spectrum4_001056, L-Glutatione,(2S)-2-Amino-5-({(2R)-1-[(carboxymethyl)amino]-1-oxo-3-sulfanyl-2-propanyl}amino)-5-oxopentanoic acid,Neuthion,NSC400639,CS-7948,y-L-Glutamyl-L-cysteinyl-glycine,NSC758199,Reduced l-glutathione,C(N-.gamma.Glu-)G,N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine,L-g-glutamyl-L-cysteinyl-glycine,gamma-glutamyl-cysteinyl-glycine,Spectrum3_000946,Glutathion,(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid,Glutide,KBio2_000899,Ledac,L-Glutathione reduced, cell culture tested, BioReagent, >=98.0%, powder,SPECTRUM1502248, Copren,DB00143,L-Glutathione reduce,Panaron,Copren, Glutide,glutathione reduced,Spectrum_000419,GLUTATHIONE [EP MONOGRAPH],GLUTATHIONE [VANDF],SMR000857220,HMS500D17,L-Glutathione reduced form,Q116907,DivK1c_000075,glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-,ReadiSorb,Pharmakon1600-01502248,NSC-758199,L-Glutathione reduced, BioXtra, >=98.0%,CCG-38876, gamma-L-Glutamyl-L-cysteinylglycine,Glycine, L-gamma-glutamyl-L-cysteinyl-,C00051,L-Glutathione reduced, 97.0%, Glutathion,GLUTATHIONE [II],1oe8,glutathione; l-glutathione reduced; 5-l-glutamyl-l-cysteinylglycine; gamma-l-glutamyl-l-cysteinylglycine; gsh,Tathion (TN),SCHEMBL9167,Tox21_111371_1,(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid,KBio3_002012,(S)-2-Amino-5-((R)-1-(carboxymethylamino)-3-mercapto-1-oxopropan-2-ylamino)-5-oxopentanoic acid,Pharm Biol 11: 539 (1968),(S)-2-Amino-5-(((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-5-oxopentanoic acid,1oe7,HMS1921N22,D00014,BenzenaMine, 2-[(4-Methoxyphenyl)Methoxy]-,SBI-0051743.P002,Glutathione [JAN],CHEBI:16856,AB00443568_03,bmse000956,L-?-glutamyl-L-cysteinyl-glycine,Glutathione, Pharmaceutical Secondary Standard; Certified Reference Material,Glutathione (reduced),Isethion,N5-((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)-L-glutamine,DTXSID6023101,gamma-L-Glutamyl-L-cysteinylglycine,SR-05000002567-1,CHEMBL1543, Tathion, gamma-L-glutamyl-L-cysteinyl-glycine,SR-05000002567-2,Glutathione, European Pharmacopoeia (EP) Reference Standard,Tox21_111371,NCGC00264046-02, Ledac,Glutathione [BAN:JAN],Glutathione (JP17),MLS001333069,L-glutamyl-L-cysteinylglycine, glutathione red,glutathione,1r4w, gamma-L-Glutamylcysteinylglycine,5-L-Glutamyl-L-cysteinylglycine,(gamma-Glutamylcysteine)n-glycine,Glutathione, Reduced,CCRIS 2094,L-Glutatione,G0074,L-?-glutamyl-L-cysteinylglycine,Glutinal, Neuthion,C02471,Glutatiol,MFCD00065939,NINDS_000075,L-Glutathione reduced, >=98.0%,Glutathione, Reduced Form,KBio2_006035,L-Glutathione,A866658,Glutathione (Reduced type),GLUTATHIONE [MART.],KBioGR_001352,Glutathione;,GSH;gamma-L-Glutamyl-L-cysteinyl-glycine, Glutathione-SH,Triptide,106272-20-2,1lbk,Glutham,Tathion, Glutathione (reduced), Glutinal,L-gamma-glutamyl-L-cysteinylglycine,KBio1_000075,L-Glutathione reduced,L-Glutathione, reduced, 70-18-8,Tathione,L-Glutathione reduced, Vetec(TM) reagent grade, >=98%,Glutathione-SH,s4606, L-Glutathione reduced, Tathione,Glutatione,G-3980,CAS-70-18-8,Reduced Glutathione,(S),ZINC3830891,KBioSS_000899,red. glutathione,.gamma.-L-Glutamyl-L-cysteinyl-glycine,N-(N-L-.gamma.-Glutamyl-L-cysteinyl)glycine, Isethion,Aec glutathione,P19615,SR-05000002567,phytochelatins,GLUTATHIONE [USP-RS],GLUTATHIONE [WHO-DD], Deltathione,95687-20-0, Glutathione [JAN], Glutatiol,L-gamma-glutamyl-L-cysteinyl-glycine, Panaron,DS-14675,GSH,bmse000185,GAN16C9B8O,Bakezyme RX,AKOS015999135,(2S)-2-AMINO-4-{[(1R)-1-[(CARBOXYMETHYL)CARBAMOYL]-2-SULFANYLETHYL]CARBAMOYLBUTANOIC ACID, red. glutathione,GLUTATHIONE [INCI],N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine,70-18-8

Market name: reduced glutathione


Estimated data

Solubility: -1.017 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 39.8% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.